Intravenous (IV) Solution Market Research Report- Global Forecast to 2022

Intravenous (IV) Solution Market Research Report- Global Forecast to 2022

ID: MRFR/HC/0727-CRR | April, 2017 | Region: Global | 121 pages | Cooked Research Reports

Global Intravenous (IV) Solution Market Information, by Type (Total Parenteral Solution, Peripheral Parenteral Solution), by Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion and Others), by End User (Hospitals & Clinics, Ambulatory and Homecare) - Forecast to 2022


Market Synopsis of Global Intravenous (IV) Solution Market:
Market Scenario:
Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.  


Global Intravenous (IV) Solution Market, by Type, 2016 (%):

Intravenous Solution Market
Intended Audience



  • Intravenous (IV) Solution Manufacturer

  • Intravenous (IV) Solution Vendors

  • Pharmaceutical & Biotechnology Companies

  • Market Research and Consulting Service Providers 


Key Finding



  • The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022

  • By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016

  • By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016 


Key Players for Global Intravenous (IV) Solution Market:
Some of the key players in this market are: ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.


Segments:
Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.


Regional Analysis of Global Intravenous (IV) Solution Market:
The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases. 
Asia-Pacific region is the fastest growing market for real time health monitoring devices, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.                       


The report for Global Intravenous (IV) Solution Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions


 

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 SCOPE OF STUDY

2.2 RESEARCH OBJECTIVE

2.3 ASSUMPTIONS & LIMITATIONS

2.3.1 ASSUMPTIONS

2.3.2 LIMITATIONS

2.4 MARKET STRUCTURE

3.1 PRIMARY RESEARCH

3.2 SECONDARY RESEARCH

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF THE CHRONIC DISEASES

4.2.2 RISE OF CHOLERA

4.2.3 GROWING ACCEPTANCE OF VITAMIN C INTRAVENOUS FOR COLORECTAL CANCER

4.3 RESTRAINTS

4.3.1 PRESENCE OF STRINGENT GOVERNMENT REGULATIONS

4.4 OPPORTUNITIES

4.4.1 RISING CONTINUOUS DEMAND OF IV SOLUTIONS IN U.S.

4.5 CHALLENGE

4.5.1 INCREASING VITAMIN C INTRAVENOUS THERAPY PRICES

4.6 MEGA TRENDS

4.7 MACROECONOMIC INDICATORS

5.1 PORTERS FIVE FORCES ANALYSIS

5.1.1 INTRODUCTION

5.1.2 BARGAINING POWER OF SUPPLIERS

5.1.3 BARGAINING POWER OF BUYERS

5.1.4 THREAT OF SUBSTITUTES

5.1.5 RIVALRY

5.1.6 THREAT OF NEW ENTRANTS

5.2 VALUE CHAIN ANALYSIS

5.2.1 INTRODUCTION

5.2.2 INPUTS

5.2.3 RESEARCH & DEVELOPMENT

5.2.4 DEVELOPMENT STAGE

5.2.5 MANUFACTURING PROCESS OF IV SOLUTIONS

5.2.6 MARKETING AND DISTRIBUTION

5.3 DEMAND SUPPLY GAP ANALYSIS

5.4 PRICE FACTOR ANALYSIS

5.5 INVESTMENT FEASIBILITY ANALYSIS

6.1 INTRODUCTION

6.2 PERIPHERAL PARENTERAL NUTRITION

6.3 TOTAL PARENTERAL NUTRITION

7.1 INTRODUCTION

7.2 AMINO ACID SOLUTION

7.3 CARBOHYDRATES

7.4 VITAMINS & MINERALS

7.5 PARENTERAL LIPID EMULSION

7.6 OTHER SOLUTIONS

8.1 INTRODUCTION

8.2 HOSPITAL & CLINICS

8.3 AMBULATORY

8.4 HOME CARE

9.1 INTRODUCTION

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 ITALY

9.3.4 UK

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 JAPAN

9.4.2 CHINA

9.4.3 INDIA

9.4.4 REPUBLIC OF KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA PACIFIC

9.5 MIDDLE EAST & AFRICA

9.5.1 UAE

9.5.2 SAUDI ARABIA

9.5.3 EGYPT

9.5.4 REST OF MIDDLE EAST & AFRICA

11.1 BAXTER

11.1.1 COMPANY OVERVIEW

11.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

11.1.3 FINANCIAL OVERVIEW

11.1.4 KEY DEVELOPMENT

11.1.5 SWOT ANALYSIS

11.2 FRESENIUS GROUP

11.2.1 COMPANY OVERVIEW

11.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

11.2.3 FINANCIAL OVERVIEW

11.2.4 KEY DEVELOPMENT

11.2.5 SWOT ANALYSIS

11.3 BRAUN MELSUNGEN AG

11.3.1 OVERVIEW

11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

11.3.3 FINANCIAL UPDATES

11.3.4 KEY DEVELOPMENT

11.3.5 SWOT ANALYSIS

11.4 ICU MEDICAL, INC.

11.4.1 COMPANY OVERVIEW

11.4.2 PRODUCT OVERVIEW

11.4.3 FINANCIALS

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.5 GRIFOLS S.A

11.5.1 COMPANY OVERVIEW

11.5.2 PRODUCT OVERVIEW

11.5.3 FINANCIAL OVERVIEW

11.5.4 KEY DEVELOPMENT

11.5.5 SWOT ANALYSIS

11.6 TERUMO MEDICAL CORPORATION

11.6.1 COMPANY OVERVIEW

11.6.2 PRODUCT OVERVIEW

11.6.3 FINANCIAL OVERVIEW

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.7 AMANTA HEALTHCARE

11.7.1 COMPANY OVERVIEW

11.7.2 PRODUCT OVERVIEW

11.7.3 FINANCIAL OVERVIEW

12.1 KEY FINDINGS

12.1.1 FROM CEO’S VIEW POINT

12.1.2 UNMET NEEDS

12.2 KEY COMPANIES TO WATCH

13.1 DISCUSSION BLUE PRINT

13.2 REFERENCES

TABLE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2014-2022)
TABLE 2 GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 3 GLOBAL TOTAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 4 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 5 GLOBAL AMINO ACID SOLUTION MARKET BY REGION USD MILLION (2014-2022)
TABLE 6 GLOBAL CARBOHYDRATES MARKET BY REGION USD MILLION (2014-2022)
TABLE 7 GLOBAL VITAMINS & MINERALS MARKET BY REGION USD MILLION (2014-2022)
TABLE 8 GLOBAL PARENTERAL LIPID EMULSION MARKET BY REGION USD MILLION (2014-2022)
TABLE 9 GLOBAL OTHER SOLUTIONS MARKET BY REGION USD MILLION (2014-2022)
TABLE 10 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2014-2022)
TABLE 11 GLOBAL HOSPITAL & CLINICS MARKET BY REGION USD MILLION (2014-2022)
TABLE 12 GLOBAL AMBULATORY MARKET BY REGION USD MILLION (2014-2022)
TABLE 13 GLOBAL HOME CARE MARKET BY REGION USD MILLION (2014-2022)
TABLE 14 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2014-2022)
TABLE 15 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 16 NORTH AMERICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 17 NORTH AMERICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 18 NORTH AMERICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 19 US IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 20 US IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 21 US IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 22 CANADA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 23 CANADA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 24 CANADA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 25 EUROPE IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 26 EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 27 EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 28 EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 29 GERMANY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 30 GERMANY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 31 GERMANY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 32 FRANCE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 33 FRANCE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 34 FRANCE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 35 ITALY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 36 ITALY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 37 ITALY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 38 UK IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 39 UK IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 40 UK IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 41 SPAIN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 42 SPAIN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 43 SPAIN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 44 REST OF EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 45 REST OF EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 46 REST OF EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 47 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 48 ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 49 ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 50 ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 51 JAPAN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 52 JAPAN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 53 JAPAN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 54 CHINA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 55 CHINA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 56 CHINA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 57 INDIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 58 INDIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 59 INDIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 60 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 61 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 62 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 63 AUSTRALIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 64 AUSTRALIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 65 AUSTRALIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 66 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 67 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 68 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 69 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 70 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 71 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 72 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 73 UAE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 74 UAE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 75 UAE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 76 SAUDI ARABIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 77 SAUDI ARABIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 78 SAUDI ARABIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 79 EGYPT IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 80 EGYPT IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 81 EGYPT IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 82 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 83 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 84 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 85 BAXTER: KEY DEVELOPMENT
TABLE 86 FRESENIUS KABI AG: KEY DEVELOPMENT
TABLE 87 BRAUN MELSUNGEN AG: KEY DEVELOPMENT
TABLE 88 ICU MEDICAL INC.: KEY DEVELOPMENT
TABLE 89 GRIFOLS S.A. : KEY DEVELOPMENTS
TABLE 90 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS

FIGURE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPE, 2016 (%)
FIGURE 2 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2016 (%)
FIGURE 3 GLOBAL IV SOLUTIONS MARKET, BY END USER, 2016 (%)
FIGURE 4 GLOBAL IV SOLUTIONS MARKET, BY REGION, 2016 (%)
FIGURE 5 GLOBAL IV SOLUTIONS: MARKET STRUCTURE
FIGURE 6 RESEARCH PROCESS
FIGURE 7 GLOBAL IV SOLUTIONS MARKET: MARKET DYNAMICS
FIGURE 8 GROWTH DRIVERS: IMPACT ANALYSIS
FIGURE 9 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2016 & 2022)
FIGURE 10 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2016 & 2022)
FIGURE 11 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2016 & 2022)
FIGURE 12 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2016 & 2022)
FIGURE 13 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 14 EUROPE IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 15 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 16 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 17 COMPANY SHARE ANALYSIS
FIGURE 18 BAXTER: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 19 BAXTER: GEOGRAPHICAL MIX
FIGURE 20 BAXTER: OPERATING SEGMENTS
FIGURE 21 BAXTER: HOSPITAL PRODUCTS SEGMENT REVENUE
FIGURE 22 BAXTER: SWOT ANALYSIS
FIGURE 23 FRESENIUS GROUP: RECENT FINANCIAL: REVENUE (EURO MILLION) & R&D EXPENSES (%)
FIGURE 24 FRESENIUS GROUP: GEOGRAPHICAL MIX
FIGURE 25 FRESENIUS GROUP: OPERATING SEGMENTS
FIGURE 26 FRESENIUS GROUP: FRESENIUS KABI SEGMENT REVENUE
FIGURE 27 FRESENIUS KABI AG: SWOT ANALYSIS
FIGURE 28 BRAUN MELSUNGEN AG: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 29 BRAUN MELSUNGEN AG: BUSINESS REVENUE
FIGURE 30 BRAUN MELSUNGEN AG: B.BRAUN HOSPITAL CARE SEGMENT REVENUE
FIGURE 31 BRAUN MELSUNGEN AG: GEOGRAPHICAL REVENUE
FIGURE 32 BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 33 ICU MEDICAL, INC: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 34 ICU MEDICAL, INC: GEOGRAPHICAL MIX
FIGURE 35 ICU MEDICAL, INC: SEGMENTAL MIX
FIGURE 36 ICU MEDICAL, INC.: INFUSION THERAPY SEGMENT REVENUE
FIGURE 37 ICU MEDICAL, INC: SWOT ANALYSIS
FIGURE 38 GRIFOLS S.A FINANCIAL OVERVIEW: RECENT FINANCIAL: REVENUE (US$ MILLION)
FIGURE 39 GRIFOLS S.A: RECENT FINANCIAL: OPERATING SEGMENTS
FIGURE 40 GRIFOLS S.A.: HOSPITAL SEGMENT REVENUE
FIGURE 41 GRIFOLS S.A FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 42 SWOT ANALYSIS GRIFOLS S.A
FIGURE 43 TERUMO MEDICAL CORPORATION: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 44 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW SEGMENTAL OVERVIEW
FIGURE 45 TERUMO MEDICAL CORPORATION: GENERAL HOSPITAL COMPANY SEGMENT REVENUE
FIGURE 46 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 47 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW GEOGRAPHICAL OVERVIEW
FIGURE 48 SWOT ANALYSIS